Procter & Gamble (NYSE:PG – Get Free Report) and USANA Health Sciences (NYSE:USNA – Get Free Report) are both consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.
Insider & Institutional Ownership
65.8% of Procter & Gamble shares are held by institutional investors. Comparatively, 54.2% of USANA Health Sciences shares are held by institutional investors. 0.2% of Procter & Gamble shares are held by insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Volatility and Risk
Procter & Gamble has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and target prices for Procter & Gamble and USANA Health Sciences, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Procter & Gamble | 0 | 11 | 15 | 0 | 2.58 |
| USANA Health Sciences | 2 | 0 | 0 | 0 | 1.00 |
Procter & Gamble presently has a consensus target price of $171.76, suggesting a potential upside of 1.45%. Given Procter & Gamble’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Procter & Gamble is more favorable than USANA Health Sciences.
Profitability
This table compares Procter & Gamble and USANA Health Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Procter & Gamble | 18.23% | 31.02% | 12.92% |
| USANA Health Sciences | -2.34% | 3.56% | 2.62% |
Valuation and Earnings
This table compares Procter & Gamble and USANA Health Sciences”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Procter & Gamble | $87.03 billion | 4.51 | $16.05 billion | $6.64 | 25.50 |
| USANA Health Sciences | $925.26 million | 0.26 | $10.76 million | ($1.15) | -11.29 |
Procter & Gamble has higher revenue and earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Procter & Gamble, indicating that it is currently the more affordable of the two stocks.
Summary
Procter & Gamble beats USANA Health Sciences on 12 of the 14 factors compared between the two stocks.
About Procter & Gamble
The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.
About USANA Health Sciences
USANA Health Sciences, Inc. develops and sells nutritional supplements, personal care products and foods. Its offerings include vitamins and other nutrition products, skincare products under the Celavive brand, and nutrition bars. Founded in 1992 by Myron Wentz, the company uses a direct-selling model, with independent Associates and other sales channels connecting its products with customers. USANA serves markets across North America, Asia-Pacific and other international regions.
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
